NCT01848834 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) Status COMPLETED Phase PHASE1
NCT01848756 Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT01846429 Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain Status TERMINATED Phase PHASE1
NCT01843140 Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01842893 Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer Status COMPLETED Phase PHASE3
NCT01839721 Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation Status COMPLETED Phase PHASE3
NCT01839617 Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery Status UNKNOWN Phase NA
NCT01837173 Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy Status UNKNOWN Phase N/A
NCT01832857 Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients Status TERMINATED Phase PHASE2
NCT01827761 Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258 Status COMPLETED Phase N/A
NCT01827644 Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01827514 Studying Erythropoietin Receptor Presence and Function in Human Cancer Specimens Status UNKNOWN Phase N/A
NCT01813474 Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT01812616 A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01812603 A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1/PHASE2